Timothy Bopp, MD
Orthopaedic Surgery · Bismarck, NDNPI 1124046016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Stryker at 38.3% of the total. Reporting peaked in 2019 at $1,581 and has fallen 59.0% since, to $648 in 2025.
Across 85 payments — averaging $50.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Orthalign Inc$892
- Johnson & Johnson$698
- Smith+Nephew$173
- Innovation Technologies Inc$167
- Heron Therapeutics, Inc.$133
- plus $603 from 12 others
What the payments were for
- Speaking & faculty fees$561%
- Food & beverage$4,26599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 22 | $1,655 |
| Orthalign Inc | 10 | $892 |
| Johnson & Johnson(2 entities) | 15 | $698 |
| Smith+Nephew | 7 | $173 |
| Innovation Technologies Inc | 4 | $167 |
| Heron Therapeutics, Inc. | 3 | $133 |
| Sanara Medtech Inc. | 2 | $116 |
| Pacira Therapeutics, Inc. | 5 | $81 |
| Xtant Medical Inc | 1 | $70 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Kerecis Limited | 3 | $57 |
| Zimmer Biomet | 1 | $49 |
| Vertex | 2 | $43 |
| Bioventus LLC | 1 | $41 |
| Pfizer | 2 | $32 |
| Medical Device Business Services, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $17 |
| Osiris Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,196
- ORTHALIGN PLUS$362
- TRIATHLON$301
- ACTIS$123
How this compares
$4,321 in reported general payments places this provider in the 60th percentile of 61 orthopaedic surgery providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 15 | $553 |
| Amoxicillin | 314 | $406 |
| Meloxicam | 57 | $196 |
| Clindamycin Hcl | 38 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bismarck
- Brian DahlBismarck$31K
- Anthony KaschBismarck$5K
- Laura BruseBismarck$4K
- Duncan AckermanBismarck$3K
- Brock NorrieBismarck$3K
- Derrick CoteBismarck$3K
- Timothy JuelsonBismarck$3K
- Troy PierceBismarck$3K
- Ian FyfeBismarck$1K
- Chad CarlsonBismarck$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.